| Product Name | ABT-494(Upadacitinib) Free base |
|---|---|
| CAS | 1310726-60-3 |
| Formula | C₁₇H₁₉F₃N₆O |
| MW | 380.37 |
| Appearance | White to yellow powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | |
|---|---|---|---|---|---|
|
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible. |
|||||
| Product Name | ABT-494(Upadacitinib) Free base |
|---|---|
| CAS | 1310726-60-3 |
| Formula | C₁₇H₁₉F₃N₆O |
| MW | 380.37 |
| Appearance | White to yellow powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Upadacitinib, also known as ABT-494, is a potent and selective JAK inhibitors in development for rheumatoid arthritis. ABT-494 is approximately 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. ABT-494 demonstrates efficacy in rat arthritis models. Preliminary evidence suggests that compared to tofacitinib, ABT-494 may spare Jak2 and Jak3 dependent signaling.